Last Update 16 Nov 25
Fair value Decreased 1.78%CL: Organic Sales Momentum Will Rebound As Near-Term Headwinds Ease
Colgate-Palmolive's analyst consensus price target was revised downward from approximately $88.84 to $87.26. Analysts cite a soft third quarter, moderated growth expectations, and ongoing category headwinds as key factors behind the adjustment.
Analyst Commentary
Analyst perspectives on Colgate-Palmolive following recent earnings highlight a balance of encouraging signs and ongoing challenges, both of which have shaped recent price target adjustments.
Bullish Takeaways- Bullish analysts see the third quarter as a potential low point, with expectations for organic sales growth to improve as temporary pressures subside.
- A strong brand portfolio and resilient brand equity continue to provide support for the company’s competitive positioning, especially in key emerging markets like Latin America.
- Some analysts maintain positive outlooks based on the company’s execution and ability to recover from short-term headwinds as comparisons become more favorable in upcoming quarters.
- The maintenance of Buy and Overweight ratings from several firms indicates sustained confidence in Colgate-Palmolive’s long-term fundamentals and ability to capitalize on improved market conditions.
- Bearish analysts point to ongoing category headwinds that are likely to persist in the near term, which tempers expectations for immediate recovery.
- Recent model adjustments account for muted and decelerating growth trends in certain personal care segments since the prior quarter.
- Widespread estimate cuts for topline and earnings per share reflect a broader industry challenge within consumer staples, which impacts the company’s valuation prospects.
- Some projections remain more neutral, with price targets reflecting less room for upside as headwinds and slower momentum are expected to weigh on near-term performance.
What's in the News
- Colgate-Palmolive completed the repurchase of 5,887,029 shares, totaling $515.76 million, as part of the buyback announced on March 20, 2025. The most recent tranche, from July 1, 2025 to September 30, 2025, saw the company buy back 3,052,859 shares for $258.6 million (Key Developments).
- The company updated its 2025 earnings guidance. It now projects net sales will rise in the low single digits, with organic sales growth guidance reduced to 1% to 2%. This reflects a slowdown from previous estimates and incorporates the impact of exiting private label pet sales (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has declined from $88.84 to $87.26, reflecting a modest decrease in projected fair value.
- Discount Rate has risen slightly from 6.78% to 6.96%, which indicates a higher perceived risk profile or cost of capital.
- Revenue Growth estimates have increased marginally, moving from 3.33% to 3.45%.
- Net Profit Margin is up modestly from 15.75% to 15.81%.
- Future P/E has decreased from 23.98x to 23.49x, which suggests lower expectations for future earnings multiples.
Key Takeaways
- Expansion in oral care and focus on emerging markets, with premiumization and innovation, drive sustained volume growth and strengthen global brand positioning.
- Investment in AI, digital transformation, and productivity boosts efficiencies, enabling reinvestment into growth and supporting stable margins and resilience against market cycles.
- Persistent cost pressures, cautious consumer behavior, and competitive challenges in major markets are constraining margin expansion, topline growth, and long-term revenue prospects.
Catalysts
About Colgate-Palmolive- Manufactures and sells consumer products in the United States and internationally.
- Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally-supporting top-line organic sales acceleration and improved pricing power.
- Emerging markets such as India, Latin America, and Southeast Asia-where rising incomes and urbanization are growing the addressable customer base-remain a strategic focus with stepped-up innovation, brand investment, and price tiering, sustaining long-term volume and revenue growth.
- Continued investments in AI, digital transformation, and omnichannel demand generation are expected to enhance operational efficiency, customer reach, and data-driven marketing, translating into greater sales effectiveness and margin resilience.
- Productivity and restructuring initiatives ($200–$300 million over three years) are designed to free up resources for innovation, digital, and R&D investments, enabling incremental margin expansion and additional reinvestment for growth.
- Category stabilization and long-term brand strength, particularly in daily-use, trusted segments (oral care, pet nutrition), position Colgate-Palmolive to outperform peers as consumer confidence rebounds, supporting consistent earnings growth and de-risking revenue from cyclical downturns.
Colgate-Palmolive Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming Colgate-Palmolive's revenue will grow by 3.8% annually over the next 3 years.
- Analysts assume that profit margins will increase from 14.5% today to 15.5% in 3 years time.
- Analysts expect earnings to reach $3.5 billion (and earnings per share of $4.43) by about September 2028, up from $2.9 billion today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 26.1x on those 2028 earnings, up from 23.4x today. This future PE is greater than the current PE for the US Household Products industry at 21.6x.
- Analysts expect the number of shares outstanding to decline by 1.08% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 6.78%, as per the Simply Wall St company report.
Colgate-Palmolive Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Consumer caution and category softness in key markets like North America, Brazil, and India could persist due to elevated food inflation and macroeconomic uncertainty, potentially constraining volume growth and revenue.
- Rising raw material and packaging costs, particularly for palm oil and fats, are significantly impacting gross margin, and relief is uncertain, posing ongoing pressure on net margins and profitability.
- Increased focus on price pack architecture and value offerings in response to cautious consumers and lower category inflation may limit the company's ability to drive premium pricing, potentially compressing margins and slowing topline growth.
- Company performance in China and India is being challenged by local market dynamics, with China's Hawley & Hazel business requiring significant repositioning in a highly competitive e-commerce environment and India experiencing urban market sluggishness, both of which could hinder long-term revenue growth in these important markets.
- Continued exposure to private label competition, especially in the pet food category and key emerging markets, along with the exit from private label production, could negatively impact reported sales growth and overall earnings during the transition period.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $95.222 for Colgate-Palmolive based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $106.0, and the most bearish reporting a price target of just $83.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $22.4 billion, earnings will come to $3.5 billion, and it would be trading on a PE ratio of 26.1x, assuming you use a discount rate of 6.8%.
- Given the current share price of $84.28, the analyst price target of $95.22 is 11.5% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

